173 related articles for article (PubMed ID: 32486166)
1. Albendazole-Induced SIRT3 Upregulation Protects Human Leukemia K562 Cells from the Cytotoxicity of MCL1 Suppression.
Wang LJ; Liou LR; Shi YJ; Chiou JT; Lee YC; Huang CH; Huang PW; Chang LS
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486166
[TBL] [Abstract][Full Text] [Related]
2. Non-mitotic effect of albendazole triggers apoptosis of human leukemia cells via SIRT3/ROS/p38 MAPK/TTP axis-mediated TNF-α upregulation.
Wang LJ; Lee YC; Huang CH; Shi YJ; Chen YJ; Pei SN; Chou YW; Chang LS
Biochem Pharmacol; 2019 Apr; 162():154-168. PubMed ID: 30414389
[TBL] [Abstract][Full Text] [Related]
3. AMPK inhibition induces MCL1 mRNA destabilization via the p38 MAPK/miR-22/HuR axis in chronic myeloid leukemia cells.
Lee YC; Chiou JT; Chang LS
Biochem Pharmacol; 2023 Mar; 209():115442. PubMed ID: 36720359
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of EGFR pathway promotes the cytotoxicity of ABT-263 in human leukemia K562 cells by blocking MCL1 upregulation.
Lee YC; Wang LJ; Huang CH; Chiou JT; Shi YJ; Chang LS
Biochem Pharmacol; 2020 Aug; 178():114047. PubMed ID: 32446890
[TBL] [Abstract][Full Text] [Related]
5. CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells.
Chiou JT; Huang CH; Wu TH; Wang LJ; Lee YC; Huang PW; Chang LS
Toxicol Appl Pharmacol; 2022 Jan; 435():115847. PubMed ID: 34963561
[TBL] [Abstract][Full Text] [Related]
6. BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells.
Chiou JT; Lee YC; Wang LJ; Chang LS
Chem Biol Interact; 2022 Jul; 361():109978. PubMed ID: 35561756
[TBL] [Abstract][Full Text] [Related]
7. Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells.
Chiou JT; Lee YC; Huang CH; Shi YJ; Wang LJ; Chang LS
Toxicol Appl Pharmacol; 2020 Jan; 387():114857. PubMed ID: 31837377
[TBL] [Abstract][Full Text] [Related]
8. ABT-263-induced MCL1 upregulation depends on autophagy-mediated 4EBP1 downregulation in human leukemia cells.
Lee YC; Wang LJ; Huang CH; Shi YJ; Chang LS
Cancer Lett; 2018 Sep; 432():191-204. PubMed ID: 29913235
[TBL] [Abstract][Full Text] [Related]
9. NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells.
Chiou JT; Huang NC; Huang CH; Wang LJ; Lee YC; Shi YJ; Chang LS
J Cell Physiol; 2021 Nov; 236(11):7356-7375. PubMed ID: 33982799
[TBL] [Abstract][Full Text] [Related]
10. GSK3β suppression inhibits MCL1 protein synthesis in human acute myeloid leukemia cells.
Lee YC; Shi YJ; Wang LJ; Chiou JT; Huang CH; Chang LS
J Cell Physiol; 2021 Jan; 236(1):570-586. PubMed ID: 32572959
[TBL] [Abstract][Full Text] [Related]
11. Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK/c-Jun-mediated BCL2L1 expression.
Changchien JJ; Chen YJ; Huang CH; Cheng TL; Lin SR; Chang LS
Toxicol Appl Pharmacol; 2015 Apr; 284(1):33-41. PubMed ID: 25684043
[TBL] [Abstract][Full Text] [Related]
12. BCL2L1 inhibitor A-1331852 inhibits MCL1 transcription and triggers apoptosis in acute myeloid leukemia cells.
Chiou JT; Wu YY; Lee YC; Chang LS
Biochem Pharmacol; 2023 Sep; 215():115738. PubMed ID: 37562509
[TBL] [Abstract][Full Text] [Related]
13. SIRT3, PP2A and TTP protein stability in the presence of TNF-α on vincristine-induced apoptosis of leukaemia cells.
Wang LJ; Chiou JT; Lee YC; Huang CH; Shi YJ; Chang LS
J Cell Mol Med; 2020 Feb; 24(4):2552-2565. PubMed ID: 31930676
[TBL] [Abstract][Full Text] [Related]
14. A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia.
Ramsey HE; Fischer MA; Lee T; Gorska AE; Arrate MP; Fuller L; Boyd KL; Strickland SA; Sensintaffar J; Hogdal LJ; Ayers GD; Olejniczak ET; Fesik SW; Savona MR
Cancer Discov; 2018 Dec; 8(12):1566-1581. PubMed ID: 30185627
[TBL] [Abstract][Full Text] [Related]
15. Hydroquinone destabilizes BIM mRNA through upregulation of p62 in chronic myeloid leukemia cells.
Lee YC; Chiou JT; Wang LJ; Chang LS
Biochem Pharmacol; 2022 May; 199():115017. PubMed ID: 35346662
[TBL] [Abstract][Full Text] [Related]
16. Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition.
Chiou JT; Lee YC; Chang LS
Biochem Pharmacol; 2023 Dec; 218():115934. PubMed ID: 37989415
[TBL] [Abstract][Full Text] [Related]
17. Confounding off-target effects of BH3 mimetics at commonly used concentrations: MIM1, UMI-77, and A-1210477.
Mallick DJ; Soderquist RS; Bates D; Eastman A
Cell Death Dis; 2019 Feb; 10(3):185. PubMed ID: 30796196
[TBL] [Abstract][Full Text] [Related]
18. Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression.
Chiou JT; Chang LS
Apoptosis; 2024 Apr; 29(3-4):503-520. PubMed ID: 38066391
[TBL] [Abstract][Full Text] [Related]
19. Cytarabine-induced destabilization of MCL1 mRNA and protein triggers apoptosis in leukemia cells.
Chiou JT; Hsu CC; Hong YC; Lee YC; Chang LS
Biochem Pharmacol; 2023 May; 211():115494. PubMed ID: 36924905
[TBL] [Abstract][Full Text] [Related]
20. The suppressive effect of arsenic trioxide on TET2-FOXP3-Lyn-Akt axis-modulated MCL1 expression induces apoptosis in human leukemia cells.
Chen YJ; Huang CH; Shi YJ; Lee YC; Wang LJ; Chang LS
Toxicol Appl Pharmacol; 2018 Nov; 358():43-55. PubMed ID: 30213730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
